Fundraising Fox
Iconovo
Sweden, SE · 1 known investors
Find your way into Iconovo
Each arrow is one introduction. Sign up to fill in the first one.
332 people can intro you to Orest
Ask Johan Lund to introduce you to Orest Lastow
You →Johan · together at AstraZeneca →Orest
Sign up to find every way you can get introduced to Iconovo
- Your email: who you already know at Iconovo, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Iconovo team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Iconovo develops advanced inhaler platforms and dry powder formulations optimized together to deliver medicines through inhalation across multiple therapeutic areas. The company partners with pharmaceutical manufacturers to create effective alternatives to tablets and injections, generating revenue through development partnerships, milestone payments, and royalties.
Founders & leadership
OL
Orest LastowFounderOrest Lastow is founder of Iconovo, which develops dry powder inhalation platforms and formulations for pharmaceutical delivery. He holds expertise in aerosol science, device development, and inhalation technology, and teaches aerosol drug delivery at Lund University.
Investors · 1
Frequently asked questions
- What does Iconovo do?
- Iconovo develops advanced inhaler platforms and dry powder formulations optimized together to deliver medicines through inhalation across multiple therapeutic areas. The company partners with pharmaceutical manufacturers to create effective alternatives to tablets and injections, generating revenue through development partnerships, milestone payments, and royalties.
- Who founded Iconovo?
- Iconovo was founded by Orest Lastow.
- Who are Iconovo's investors?
- Iconovo's investors include FSG.
- Where is Iconovo headquartered?
- Iconovo is headquartered in Sweden, SE.